Research Use Only - Not for human consumption. 18+ only.

PT-141 vs Melanotan II

Evidence-based comparison · Updated 2026

Summary

PT-141 is the appropriate choice for treating sexual dysfunction, as it is FDA-approved and acts centrally via MC4R to enhance arousal in both men and women. Melanotan II is a research-only compound studied primarily for skin tanning and secondarily for libido effects, with a broader and less selective receptor profile. Choose PT-141 for clinical sexual health applications and consider Melanotan II only in a research context for its melanogenic properties.

Side-by-Side Comparison

PT-141Melanotan II
EvidenceAGrade ALarge human randomised controlled trials or FDA/major-authority approvedCGrade CPrimarily animal or in-vitro studies; limited human data
RegulatoryFDA ApprovedFDA ApprovedApproved by the US Food and Drug Administration for at least one indicationResearch OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only
Benefits
  • +Treats sexual dysfunction in men and women
  • +Enhances arousal and desire
  • +Works via central nervous system (not vascular like Viagra)
  • +FDA-approved for female HSDD
  • +Effective for psychological erectile dysfunction
  • +Stimulates melanogenesis (tanning)
  • +Tanning without UV exposure (photoprotection)
  • +Appetite suppression
  • +Libido enhancement
  • +May reduce sun damage risk
Dosage1-2 mg mg — As needed, 45 minutes before sexual activity250-500 mcg mcg — Daily until desired tan, then 2-3x/week maintenance
RouteSubcutaneous, IntranasalSubcutaneous
CategorySexual Health & LibidoTanning & Pigmentation

Full research page

PT-141 →

Full research page

Melanotan II →

Which Should You Choose?

PT-141 and Melanotan II share structural similarity as melanocortin receptor agonists, but differ critically in receptor selectivity: PT-141 is optimized for MC4R to produce targeted central nervous system effects on sexual function, while Melanotan II binds non-selectively across multiple melanocortin receptors, producing broader systemic effects including skin pigmentation, appetite suppression, and libido changes.

Choose PT-141 when:

  • +FDA-approved as bremelanotide for hypoactive sexual desire disorder in premenopausal women, providing a regulatory-backed safety and efficacy profile
  • +Targets sexual dysfunction specifically through CNS pathways, making it effective for both psychological erectile dysfunction and HSDD without vascular mechanism dependence
  • +Higher evidence grade and more controlled clinical trial data supporting its use for sexual arousal in both men and women

Choose Melanotan II when:

  • +Research interest in melanogenesis and UV-independent skin tanning, a mechanism not shared by PT-141
  • +Secondary appetite-suppressive effects observed in studies, which fall outside PT-141's pharmacological profile
  • +Broader melanocortin receptor activation may be relevant for researchers studying the full spectrum of the melanocortin system

Stacking PT-141 and Melanotan II is not a common or well-studied practice, and given Melanotan II's non-selective receptor binding and research-only status, combining the two introduces unpredictable additive effects and an unclear safety profile.

Frequently Asked Questions

Do PT-141 and Melanotan II produce the same libido effects through the same mechanism?⌄
Both peptides influence sexual function through the melanocortin system, but their receptor profiles differ meaningfully. PT-141 selectively activates MC4R in the hypothalamus to enhance dopamine-mediated sexual motivation and arousal. Melanotan II binds less selectively across MC1R, MC3R, MC4R, and MC5R, so its libido effects are a secondary consequence of broader receptor activation rather than a targeted CNS action. Research suggests PT-141 produces more consistent and predictable sexual function outcomes as a result.
How do the onset and duration timelines of PT-141 and Melanotan II compare for their respective primary effects?⌄
PT-141 administered subcutaneously typically produces onset of sexual arousal effects within 45 minutes to 1 hour, with effects lasting approximately 6 to 12 hours in clinical studies. Melanotan II's tanning effects are cumulative and develop over repeated dosing across days to weeks rather than producing a single-dose acute effect. For libido effects specifically, Melanotan II users in research contexts have reported onset within 1 to 4 hours of administration, though this data comes largely from uncontrolled observations rather than rigorous trials.
Can Melanotan II substitute for PT-141 when the goal is treating sexual dysfunction?⌄
Melanotan II is not an appropriate substitute for PT-141 in treating sexual dysfunction. PT-141 is FDA-approved with documented efficacy in controlled trials for HSDD and erectile dysfunction of psychological origin, while Melanotan II remains a research-only compound with no approved therapeutic indication. Melanotan II's broader receptor binding profile also produces side effects including nausea, flushing, and spontaneous erections that differ from PT-141's more targeted profile, and it lacks the regulatory oversight required for clinical use.
What are the key safety differences between PT-141 and Melanotan II that researchers and clinicians should consider?⌄
PT-141 has an established safety profile from FDA review, with the most common adverse effects being nausea, flushing, and transient blood pressure changes. Melanotan II, as a research-only compound, carries additional concerns including reports of melanocytic nevus changes, dysregulated pigmentation, and cardiovascular effects linked to its non-selective receptor activation across multiple melanocortin receptor subtypes. The absence of phase III clinical trial data for Melanotan II means its long-term safety profile is substantially less characterized than that of PT-141.

Goal-Based Guides

Broader evidence guides for the goals this comparison relates to.

Best peptides for Sexual Health→

Not sure which fits your research goals?

Use the Goal Finder

Answer 3 questions and get a personalised peptide recommendation ranked by evidence grade.

Find My Peptide →

More Comparisons

bpc 157 vs tb 500mots c vs semaglutidedsip vs melanotan iiretatrutide vs tirzepatidecjc 1295 vs ipamorelin